Will AbbVie's Growing Oncology Portfolio Aid Top-line Growth?
ABBV has been pursuing both organic and inorganic strategies to drive this expansion. While Epkinly and Elahere were added to the portfolio through acquisitions or collaborations, Emrelis is the company's first internally developed solid tumor drug and also its first lung cancer therapy. Combined with steadily rising Venclexta sales, these newer additions have helped more than offset the fall in Imbruvica sales, which have been declining due to stiff competition from novel oral therapies. Approved last month, we expect Emrelis to start contributing to AbbVie's top line beginning third-quarter 2025.
The company also has an exciting and diverse pipeline of promising new therapies in both blood cancers and solid tumors. Notably, etentamig (formerly ABBV-383), a BCMA x CD3 bispecific antibody, is currently being evaluated in a late-stage study for relapsed/refractory multiple myeloma. ABBV is also developing another c-Met targeting ADC called Temab-A (formerly ABBV-400). This drug, being evaluated in a late-stage study for metastatic colorectal cancer, is also in mid-stage development for gastroesophageal cancer. AbbVie is also conducting label expansion studies on its approved products to further strengthen its oncology footprint.
Competition in the Oncology Space
Other large players in the oncology space are AstraZeneca AZN, Merck MRK and Pfizer PFE.
For AstraZeneca, oncology sales now account for nearly 41% of total revenues. Sales in its oncology segment rose 13% in the first quarter of 2025. AstraZeneca's strong oncology performance was driven by medicines such as Tagrisso, Lynparza, Imfinzi, Calquence and Enhertu (in partnership with Daiichi Sankyo).
Merck's key oncology medicines are PD-L1 inhibitor, Keytruda and PARP inhibitor, Lynparza, which it markets in partnership with AstraZeneca. Keytruda, approved for several types of cancer, alone accounted for more than 46% of Merck's total revenues in first-quarter 2025.
Pfizer's first-quarter oncology revenues grew 7% on an operational basis, driven by drugs like Xtandi, Lorbrena, the Braftovi-Mektovi combination and Padcev. The segment now accounts for over 27% of Pfizer's total revenues.
ABBV's Price Performance, Valuation and Estimates
Shares of AbbVie have outperformed the industry year to date, as seen in the chart below.
From a valuation standpoint, AbbVie is not very cheap. Based on the price/earnings (P/E) ratio, the company's shares currently trade at 13.99 times forward earnings, slightly lower than its industry's average of 14.81. The stock is cheaper than some other large drugmakers, such as Eli Lilly and Novo Nordisk, but is priced much higher than most other large drugmakers. The stock is also trading above its five-year mean of 12.43.
The Zacks Consensus Estimate for 2025 earnings has risen from $12.21 per share to $12.28, while that for 2026 has increased from $13.99 to $14.06 over the past 60 days.
AbbVie currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Zacks Names #1 Semiconductor Stock
It's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.
With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.
See This Stock Now for Free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AstraZeneca PLC (AZN): Free Stock Analysis Report
Pfizer Inc. (PFE): Free Stock Analysis Report
Merck & Co., Inc. (MRK): Free Stock Analysis Report
AbbVie Inc. (ABBV): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
3 hours ago
- Globe and Mail
Ethereum Just Approached $3,500. 3 Reasons This Leading Cryptocurrency Is Still a Buy
Key Points Ethereum is the world's second-largest cryptocurrency by market cap. It has underperformed this year, especially compared to Bitcoin. Several developing catalysts could change this. 10 stocks we like better than Ethereum › Cryptocurrencies are rounding into form. Bitcoin, the world's largest cryptocurrency by market cap, hit fresh all-time highs of more than $123,000 on July 14. The asset's run has also sent a jolt into Ethereum (CRYPTO: ETH), which shot up to almost $3,500 per token on July 17 after having a difficult year so far. Ethereum has traded at much higher levels in the past (its record is $4,892 back in November 2021), and I think it's been a bit surprising to see the performance chart of the world's second-largest cryptocurrency diverge so much from Bitcoin's. Here are three reasons Ethereum can keep its momentum going. 1. The environment remains favorable Republicans in the House of Representatives kicked off "Crypto Week" on Monday with the goal of passing three crypto bills that are intended to create a more favorable regulatory environment for digital assets. The Genius Act is set to create a regulatory framework for stablecoins, which are digital assets backed by a commodity or currency. The Digital Asset Market Clarity Act (Clarity Act for short) would create a regulatory framework for digital assets that its backers say will provide "strong safeguards and long-overdue regulatory certainty." The Anti-CBDC (Central Bank Digital Currency) Surveillance State Act would prevent the Federal Reserve from issuing its own digital currency, which would essentially give the private sector first crack at stablecoins and other forms of innovation in the digital currency space. The Genius Act is the furthest along in the legislative process, having already been passed by the Senate. Other potential tailwinds include lower interest rates, which have historically benefited cryptocurrencies. The market is expecting the Federal Reserve to make a few cuts to its benchmark federal funds rate later this year, with more to follow in 2026. 2. Institutional interest is heating up As the regulatory environment continues to become more favorable, institutional investors and mainstream financial institutions will likely lose some of their trepidation about getting involved with cryptocurrencies. While Bitcoin could be the largest beneficiary of that, Ethereum is drawing interest as well. Recently, SharpLink Gaming purchased nearly $48.9 million worth of Ethereum. Bitmine Immersion Technologies also recently announced a $250 million private placement led by a group of top crypto investors. The plan is to follow in the footsteps of Strategy, which has tapped the capital markets to raise funds that it then uses to buy Bitcoin. But in Bitmine's case, the plan is to buy Ethereum. Part of the recent interest is around stablecoins because Tether and USDC, the two largest stablecoins, are issued on Ethereum's network. Fundstrat's Tom Lee, board chairman at Bitmine, said in a recent interview on CNBC that interest around stablecoins is set to drive Ethereum much higher this year and long term: "Stablecoins have really exploded because consumers, businesses, and banks are really interested in adopting this. The majority of stablecoins are actually transacted on the Ethereum blockchain. And if Treasury Secretary [Scott] Bessent is right, and it goes from a $250 billion market to $2 trillion, that's exponential demand for Ethereum." 3. This metric suggests Ethereum is set to close the gap with Bitcoin It's never easy to value cryptocurrencies because they don't generate earnings or cash flow -- at least, not in the traditional sense like publicly traded companies do. Still, as the asset class has grown more popular, many experts and analysts have tried to apply some sort of valuation methodology. One easy one to look at is the Ethereum-to-Bitcoin ratio, which divides the price of Ethereum by the price of Bitcoin. Currently, the ratio is at roughly 0.025. While that's not the lowest the ratio has ever been, it's definitely toward the lower end of the spectrum, looking back to 2015. Now, historical data can never predict the future. It's also possible that Bitcoin's now more prominent position, which has it viewed as a form of digital gold, will continue to send its price to new highs and create a wider disparity in the ratio. But it's also quite possible that Ethereum is undervalued right now and well positioned for a run-up. Should you invest $1,000 in Ethereum right now? Before you buy stock in Ethereum, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Ethereum wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,281!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,050,415!* Now, it's worth noting Stock Advisor's total average return is 1,058% — a market-crushing outperformance compared to 179% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025
CTV News
4 hours ago
- CTV News
Trump administration imposes limits on Mexican flights and threatens Delta alliance in trade dispute
Secretary of Transportation Sean Duffy testifies during a House Committee on Transportation and Infrastructure Oversight hearing on the Department of Transportation's Policies and Programs and Fiscal Year 2025 Budget Request on Capitol Hill, Wednesday, July 16, 2025, in Washington. (AP Photo/Rod Lamkey, Jr.) The Trump administration imposed new restrictions Saturday on flights from Mexico and threatened to end a longstanding partnership between Delta Air Lines and Aeromexico in response to limits the Mexican government placed on passenger and cargo flights into Mexico City several years ago. Transportation Secretary Sean Duffy said Mexico's actions to force airlines to move out of the main Benito Juarez International Airport to the newer Felipe Angeles International Airport more than 30 miles (48.28 kilometers) away violated a trade agreement between the two countries and gave domestic airlines an unfair advantage. Mexico is the top foreign destination for Americans with more than 40 million passengers flying there last year. 'Joe Biden and Pete Buttigieg deliberately allowed Mexico to break our bilateral aviation agreement,' Duffy said, referring to the previous president and his transportation secretary. 'That ends today. Let these actions serve as a warning to any country who thinks it can take advantage of the U.S., our carriers, and our market. America First means fighting for the fundamental principle of fairness.' All Mexican passenger, cargo and charter airlines will now be required to submit their schedules to the Transportation Department and seek government approval of their flights until Duffy is satisfied with the way Mexico is treating U.S. airlines. It's not immediately clear how Duffy's actions might affect the broader trade war with Mexico and negotiations over tariffs. A spokesperson for Mexico's President Claudia Sheinbaum didn't reply immediately to a request for comment. Sheinbaum didn't mention the new restrictions during either of her two speaking events on Saturday. Delta and Aeromexico have been fighting the Transportation Department's efforts to end their partnership that began in 2016 since early last year. The airlines have argued that it's not fair to punish them for the Mexican government's actions, and they said ending their agreement would jeopardize nearly two dozen routes and $800 million in benefits to both countries' economies that come from tourism spending and jobs. 'The U.S. Department of Transportation's tentative proposal to terminate its approval of the strategic and pro-competitive partnership between Delta and Aeromexico would cause significant harm to consumers traveling between the U.S. and Mexico, as well as U.S. jobs, communities, and transborder competition,' Delta said in a statement. Aeromexico's press office said it was reviewing the order and intended to present a joint response with Delta in the coming days. But the order terminating approval of the agreement between the airlines wouldn't take effect until October, and the airlines are likely to continue fighting that decision. The airlines said in a previous filing fighting the order that it believes the loss of direct flights would prompt over 140,000 American tourists and nearly 90,000 Mexican tourists not to visit the other country and hurt the economies of both countries with the loss of their spending. Associated Press writer Amaranta Marentes in Mexico City contributed to this report. Josh Funk, The Associated Press
Globe and Mail
5 hours ago
- Globe and Mail
If You Buy Apple With $10,000 in 2025, Will You Become a Millionaire in 10 Years?
Key Points Apple's ability to introduce inventive products and easy-to-use software has created a loyal following among consumers across the globe. This business has returned nearly $1 trillion to shareholders since the start of fiscal 2012. The stock will be higher a decade from now, but monster gains are a thing of the past. 10 stocks we like better than Apple › Apple (NASDAQ: AAPL) isn't having a great year. As of July 16, shares are down 16% in 2025. This negative trend hasn't prevented the stock from soaring 562% in the previous 10-year period. Worries about tariffs and slow progress with artificial intelligence (AI) might be the key factors on the minds of investors these days. But let's say that you're not deterred. If you buy Apple shares today with $10,000, will that starting sum turn into $1 million by 2035? Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Becoming a dominant tech enterprise Apple's success over the years has largely come down to the company's expertise in brand management, its innovative culture that consistently introduces popular products, and its design expertise that prioritizes the user experience. It's not just about the iPod, iPhone, MacBook, iPad, AirPods, or Watch, for example, but about how these devices seamlessly integrate with the software and services to create Apple's powerful ecosystem. This is one of the best businesses in the world with unmatched reach. During the first-quarter 2025 earnings call, CEO Tim Cook mentioned that there are more than 2.35 billion active Apple devices across the globe. That figure continues to creep higher over time. And it demonstrates just how ubiquitous Apple has become. Equally if not more impressive is that these products provide Apple with the opportunity to generate more recurring revenue. ''We have well over 1 billion paid subscriptions across the services on our platform," CFO Kevan Parekh said on the Q2 2025 earnings call. With an offering set that ranges from financial services like Pay and Card, all the way to TV+, Music, and Fitness+, among others, Apple is proving that's it not just a hardware company. For a business to build this kind of adoption, especially in the notoriously difficult arena of consumer technology, it requires the rare ability to truly resonate with consumers over a long period of time. Apple's brand is extremely strong, which drives customer loyalty and pricing power. Apple's services segment posted 11.6% year-over-year revenue growth in Q2 (ended March 29), faster than the business overall. And this segment reports a stellar 75.7% gross margin, driving impressive profitability for the company. Apple raked in $24.8 billion in net income during the most recent fiscal quarter. The management team hasn't shied away from returning capital to shareholders. Since the start of fiscal 2012, Apple has returned a whopping $987 billion to its investors. The vast majority has come from stock buybacks, with about $15 billion paid in dividends annually. Apple over the next decade A good rule of thumb in investing is that winners will continue winning. Apple is clearly a fantastic business that has many wonderful qualities. And it has done nothing but take care of its shareholders in the past. But investors must view the situation today and over the next decade with clarity. With sustainable earnings per share (EPS) growth, Apple's stock price will be higher in 2035, I believe. That might be the only positive perspective that I have. I don't think shares will outperform the broader S&P 500. After all, EPS is projected to increase at a yearly clip of 8.7% between fiscal 2024 and fiscal 2027, according to Wall Street consensus estimates. Extrapolating that forecast out to 2035 doesn't give investors much to be excited about. And the expensive price-to-earnings (P/E) ratio of 32.7 adds downside risk. Apple could introduce another game-changing product that eventually rivals the iPhone in terms of its financial success. However, I believe this outcome has a very low probability of happening. This brings me to the final conclusion: If you buy $10,000 worth of Apple shares today, you won't become a millionaire in 10 years. This implies a monster 100-fold increase in the stock price, or 58.5% per year. That's not a reasonable outlook to have for any company, let alone one that carries a huge $3.1 trillion market cap. Should you invest $1,000 in Apple right now? Before you buy stock in Apple, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Apple wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025
